Jounce Therapeutics Inc.

NASDAQ: JNCE · Real-Time Price · USD
1.88
0.00 (0.00%)
At close: May 03, 2023, 10:00 PM

Jounce Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
50.96M -31M -33.51M -37.37M 30K -30.09M -4.01M -26.54M
Depreciation & Amortization
442K 495K 560K 590K 643K 683K 716K 785K
Stock-Based Compensation
2.44M 2.56M 2.44M 2.83M 2.79M 2.93M 2.94M 2.83M
Other Working Capital
4.27M -1.41M 5.3M 302K -1.68M 30.15M -25.74M -10.25M
Other Non-Cash Items
145K 131K 223K 301K -29.95M 266K 199K 139K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
5.25M -3.73M 6.88M 481K -1.72M 29.39M -24.75M -10.77M
Operating Cash Flow
59.23M -31.54M -23.41M -33.17M -28.2M 3.17M -24.91M -33.55M
Capital Expenditures
-223K -240K -349K -107K -125K -90K 1K -158K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -24.93M -38.36M -13.35M -57.3M -21.27M
Sales Maturities Of Investments
14.45M 31.15M 41.05M 22.68M 16.8M 14.75M 26.78M 11.8M
Other Investing Acitivies
n/a n/a n/a n/a -1K n/a n/a n/a
Investing Cash Flow
14.23M 30.91M 40.7M -2.36M -21.68M 1.31M -30.52M -9.62M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-442K n/a 33K 409K 49K 69K -29K 91.95M
Financial Cash Flow
n/a n/a 33K 409K 49K 69K -29K 91.95M
Net Cash Flow
73.46M -630K 17.33M -35.12M -49.84M 4.55M -55.46M 48.78M
Free Cash Flow
59.01M -31.78M -23.75M -33.27M -28.33M 3.08M -24.91M -33.71M